Generic Motegrity is Available Now! - CanadaDrugstore

Generic Motegrity is Available Now!

Apotex announced the launch of Apo-Prucalopride 1 mg & 2 mg tablets, the first generic alternative to Resotran in Canada.

Comparasion Motegrity



Prucalopride is a medication designed to treat chronic constipation – a health problem characterized by infrequent and difficult passage of stools over a prolonged period, along with a range of other distressing symptoms such as abdominal bloating, flatulence, and even vomiting.

Traditional treatment options for chronic constipation involve mostly diet and lifestyle changes and/or laxatives. 1

Brand name

USA: Motegrity Europe: Resolor Canada: Resotran

The medicine can only be obtained with a prescription.

Motegrity MOTEGRITY (prucalopride succinate – tablet;oral) Manufacturer: SHIRE DEV LLC Approval date: December 14, 2018 Strength(s): EQ 1MG BASE [RLD], EQ 2MG BASE [RLD]

The cost for Motegrity oral tablet 1 mg in the USA at the time this article was written is around $465 for a supply of 30 tablets, depending on the pharmacy you visit.

Prices are for cash paying customers and may not be valid with insurance plans.


On December 7, 2011, Health Canada issued a Notice of Compliance to Janssen Inc. for the drug product, Resotran™.

Check the price for Resotran.

Resotran™ contains the medicinal ingredient prucalopride, as prucalopride succinate, which is an enterokinetic agent.


Resolor was first approved in Europe in 2009 for symptomatic treatment of chronic constipation in women and in 2015 in men in whom laxatives fail to provide adequate relief.

New Prescription Refill Prescription Over the Counter Products Terms of Sale Terms of Use Privacy Policy Spam Abuse Policy